A forest plot graph of the association between metformin use and the risk of prostate cancer is shown in Fig. 2A, while Fig. 2B and 2C show the effect of metformin use on the BCR and all-cause mortality of patients with prostate cancer after treatment, respectively. This evidence concerns the gene BCR and prostate carcinoma.